The research and development products of Pars Isotope have been updated

The list of Pars Isotope’s R&D products, categorized into three groups radionuclide generators, diagnostic products, and theranostic products has been updated and is accessible via the following link:

Since our products are related to medical, health, and pharmaceutical matters, like any other pharmaceutical product, they must undergo research phases, studies, and evaluation of their results before entering the market and being made available to the public.

Pars Isotope, as the sole authorized producer and supplier of diagnostic and therapeutic radiopharmaceuticals in Iran, in line with scientific values, consistently has new products under research, investigation, and clinical trials. These products will enter the nuclear medicine community for patient use after obtaining health approvals and proving their efficacy.

Pars Isotope, in the process of developing investigational products and conducting clinical trials, is committed to protecting the rights and health of trial participants while maintaining confidentiality of their data. The company strives to achieve valuable and scientifically valid results by adhering to pharmaceutical ethics committee approvals. Pars Isotope maintains the highest clinical, scientific, and ethical standards, incorporating all relevant policies, values, and scientific visions. Furthermore, the company considers comprehensive documentation of clinical trial protocols with full details as part of its responsibilities to enhance the scientific quality of research.